In 2006 Australia became a signatory to the chemical, biological and radiological (CBR) threats, Memorandum of Understanding (MoU) in partnership with the Defence departments of the United States, United Kingdom and Canada. The Medical Countermeasures Consortium (MCMC) is a working group under the CBR MoU and includes the Health Departments of each of those nations. [2]

Medical countermeasures (MCM) include therapeutics (drugs), vaccines, diagnostics and personal protective equipment.  Not having MCM “to chemical, biological and radiological (CBR) threats, emerging infectious diseases or pandemics is the biggest risk to our health, economy and security”. [1]

In November 2012, Australia’s Departments of Health joined the Department of Defence (DOD), which in Australia is represented by the Defence Science and Technology Organisation (DSTO) and the Office of Health Protection (OHP), who have been working with local biotechnology and medical-technology communities to identify, validate and develop national MCM-related capability and capacity. [1, 2, 3]

A 2013 DSTO commissioned the first MCM audit which recommended the establishment of a public–private partnership to create a nexus between industry best-practice project/product development disciplines with relevant capabilities in government, universities, medical research institutes and the private sector, resulting in the September 2013  formation of Medical Countermeasure Products Australia (MCPA) with Leigh Farrell is chairman of Steering Committee and Craig Rayner [6] is chairman of Development Committee. Under Next Generation Technology Fund (NGTF), part of Defense Science and Technology (DTS) group. [2, 3, 4, 5]

  • In December 2022, Dr Craig Rayner joined Moderna in Australia! He was against ivermectin in 2020!, and in 2017 authored the report to DOD warning that Australia is not prepared, as we import 90% of our drugs! [2]

In 2014 the DOD and Health is represented by the Defence Science and Technology Organisation (DSTO) and the Office of Health Protection (OHP), have been working with local biotechnology and medical-technology communities to identify, validate and develop national MCM-related capability and capacity. [2]

On August 9, 2023 Australian Senator Malcolm Roberts pointed out that this DOD agreement appears to have been designed to make pandemic response in Australia a military operation and not a civilian health operation, especially, when in July 2021, General Frewen took to the microphone in full military uniform. [6]

“The military should not be used against law-abiding civilians or against healthy civilians for the purposes of forced injections to transfer wealth to big pharma”
Senator Roberts stated

The military played a dominant role in the response to the SARS-CoV-2 virus both in the development and distribution of the COVID-19 vaccines, “a fact hidden from the general public”.  The TGA allowed the genetic therapy injectable products to enter the Provisional Registration pathway under the classification of a “vaccine”, but it appears they were also considered to be emergency “countermeasures“.  So not only were the products not considered a gene therapy, as a “countermeasure” the products circumvented the “standard steps and procedures, otherwise required for pharmaceutical products.” [7]

  • On March 2, 2020 President Donald Trump held a meeting to discuss the development of “countermeasures in the form of therapeutics and vaccines.”